CD44 and cancer: These results suggest that alternative splicing of CD44 gene transcript may play a role in the EC oncogenesis, especially in poorly differentiated cancers with highly invasive potential—possibly increased use of an alternative splicing mechanism leading to overproduction of variant forms of CD44 in excess of the standard particle.